89 results
Page 4 of 5
8-K
EX-99.1
8qddpoj8ybld r4ej5uw
4 Aug 20
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:47pm
8-K
EX-99.2
haej2nh7f3xfmk6pesz
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTACĀ® Protein Degrader
7:06am
424B5
7e8pv07bh5h2i g5e3y5
7 Nov 19
Prospectus supplement for primary offering
4:05pm
424B5
47yz o0epm8
6 Nov 19
Prospectus supplement for primary offering
5:31pm
424B3
ys2 07wnw
18 Oct 19
Prospectus supplement
5:05pm
424B3
p8nht96y7nuivyb9stui
11 Oct 19
Prospectus supplement
7:44am
S-3
mhw bb0u265bk
1 Oct 19
Shelf registration
6:37pm
8-K
7yrz0vu3bdtf7r25idx
4 Jun 19
Entry into a Material Definitive Agreement
7:18am
8-K
EX-99.1
7koyvcjzgnju7261c
1 Apr 19
Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
4:52pm
10-K
7t2 laizkwmv5zs
26 Mar 19
Annual report
4:31pm